Infant Leukemia

June 3-6, 1999, Owatonna, MN

John Kersey, MD, 
Norma Ramsay, MD,
Leslie L. Robison, Ph.D.

Infant leukemia remains one of the last major hurdles to be conquered in childhood leukemia because of its continuing very poor response to standard therapy. On the research front, epidemiologic/etiologic data are developing at a very rapid pace. Also, study of the molecular genetics of infant leukemia and insight into the genes involved in normal and pathologic states is developing at an explosive pace: providing important new insights into developmental biology, gene regulation and hematopoiesis. It is likely that research developments and questions to be discussed at this conference will have a significant impact in development of both preventative and therapeutic strategies for this interesting but devastating leukemia.